A living Cochrane review asked whether nicotine e-cigarettes help adults stop smoking long-term compared with nicotine replacement therapy (NRT). Its searches were current through 1 March 2025. The whole review included 104 completed studies with 30,366 participants, including 61 RCTs, plus non-randomized studies. The specific NRT comparison below uses a much smaller randomized subset. The review rated outcome-specific certainty with GRADE.
For the main outcome, abstinence at six months or longer, nicotine e-cigarettes increased quit rates versus NRT: risk ratio 1.55 (95% CI 1.28 to 1.88; 9 studies, 2703 participants), rated high-certainty. In absolute terms, this might mean about three more quitters per 100.
Adverse-event certainty was lower. The rate of adverse events was probably similar between groups (moderate-certainty, limited by imprecision; RR 1.00, 95% CI 0.73 to 1.37). Serious adverse events were rare, and evidence was insufficient to determine whether rates differ (low-certainty, very serious imprecision).
Across the entire living review, many studies were rated high risk of bias, including all non-randomized studies; this does not erase the high-certainty rating for the specific randomized quit-rate comparison. Safety comparisons had wider intervals and few serious events. The abstract does not report blinding or randomisation details for individual trials.
A useful interpretive question: given that most safety estimates remain imprecise, how should people weigh a high-certainty quit-rate difference against uncertain long-term safety data?
Review: PMID 41212103 · DOI 10.1002/14651858.CD010216.pub10
Написать Join — чтобы участвовать в обсуждении.